Pimavanserin augments the efficacy of atypical antipsychotic drugs in a mouse model of treatment-refractory negative symptoms of schizophrenia

2021 ◽  
pp. 113710
Author(s):  
L Rajagopal ◽  
C Ryan ◽  
A Elzokaky ◽  
ES Burstein ◽  
HY Meltzer
Keyword(s):  
Mouse Model ◽  
Atypical Antipsychotic ◽  
Negative Symptoms ◽  
Antipsychotic Drugs ◽  
Atypical Antipsychotic Drugs ◽  
Treatment Refractory

Atypical Antipsychotic Drugs in Treatment-Refractory Schizophrenia

1998 ◽  
Vol 28 (11) ◽  
pp. 618-626 ◽  
Author(s):  
Daniel W Bradford ◽  
Miranda H Chakos ◽  
Brian B Sheitman ◽  
Jeffrey A Lieberman
Keyword(s):  
Atypical Antipsychotic ◽  
Antipsychotic Drugs ◽  
Atypical Antipsychotic Drugs ◽  
Treatment Refractory

scholarly journals H1-Histamine Receptor Affinity Predicts Short-Term Weight Gain for Typical and Atypical Antipsychotic Drugs

2003 ◽  
Vol 28 (3) ◽  
pp. 519-526 ◽  
Author(s):  
Wesley K Kroeze ◽  
Sandra J Hufeisen ◽  
Beth A Popadak ◽  
Sean M Renock ◽  
SeAnna Steinberg ◽  
...  
Keyword(s):  
Weight Gain ◽  
Atypical Antipsychotic ◽  
Antipsychotic Drugs ◽  
Histamine Receptor ◽  
Short Term ◽  
Receptor Affinity ◽  
Atypical Antipsychotic Drugs

New Disulfide Route to 3-(1-Piperazinyl)-1,2-benzisothiazole. Nucleus for Atypical Antipsychotic Drugs

1999 ◽  
Vol 3 (2) ◽  
pp. 126-130 ◽  
Author(s):  
Stanley W. Walinsky ◽  
Darrell E. Fox ◽  
John F. Lambert ◽  
Terry G. Sinay
Keyword(s):  
Atypical Antipsychotic ◽  
Antipsychotic Drugs ◽  
Atypical Antipsychotic Drugs
Sign in / Sign up

Export Citation Format

Share Document